LGND Rentabilitas operasi ligand.com

Logo perusahaan publik Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals (LGND) generates revenue through the licensing of its Captisol platform and royalties, maintaining environmental compliance by keeping its own production volumes low. The operating margin breakdown demonstrates the resilience of the business model, with the value holding at 14.40. Profitability is based on partnerships with biopharmaceutical giants that make milestone payments for the use of the company's scientific developments.

LGND: Rentabilitas dodolan miturut bathi operasi Ligand Pharmaceuticals Incorporated 04.07.2022 - 20.11.2026

Ligand Pharmaceuticals (LGND) - rincian metrik lan laporan keuangan

Pambiji fundamental perusahaan:Ligand Pharmaceuticals Incorporated, LGND
Barang utama Ligand Corp

Ligand Pharmaceuticals (LGND) operates in a high-risk sector where financial stability depends directly on the commercial success of partner drugs and patent protection. By analyzing the operating margin distribution, an investor assesses the share of profit from core operations relative to total revenue, which helps identify cost management efficiency and the risks of declining royalties before taxes and interest obligations.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Rentabilitas operasi Amneal AMRX|Tingkat bathi adhedhasar bathi operasi Perrigo Company PLC|Alvotech Biopharmaceuticals - Margin operasi|Rentabilitas kegiatan operasi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Rentabilitas operasi|anipharmaceuticals.com - Tingkat bathi operasi|Margin dodolan operasi MNKD|AMPH: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.